Back
Neurogene Vs. IonQ Industry Stock Comparison
Sell
20
NGNE
Neurogene
Last Price:
25.58
Seasonality Move:
25.48%
Buy
56
IONQ
IonQ
Last Price:
36.59
Seasonality Move:
-17.85%
Sell
20
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $25.43. The Score for NGNE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
56
IonQ (IONQ)
is a Buy
Is IonQ a Buy, Sell or Hold?
- The current IonQ [IONQ] share price is $36.50. The Score for IONQ is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- IONQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NGNE Stock Price Chart
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.36 | Sell |
Relative Strength Index (14 RSI): | 38.76 | Sell |
Chaikin Money Flow: | -108001 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.71 - 58.79) | Sell |
Bollinger Bands (100): | (30.89 - 51.17) | Sell |
IONQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.9 | Buy |
Relative Strength Index (14 RSI): | 76.23 | Buy |
Chaikin Money Flow: | 16392811 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.18 - 30.56) | Buy |
Bollinger Bands (100): | (4.67 - 19.97) | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.11 | Buy |
20-day SMA: | 39.58 | Sell |
50-day SMA: | 43.45 | Sell |
200-day SMA: | 38.56 | Sell |
8-day EMA: | 25.61 | Sell |
20-day EMA: | 33.37 | Sell |
50-day EMA: | 39.56 | Sell |
200-day EMA: | 36.94 | Sell |
IONQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.45 | Buy |
20-day SMA: | 25.67 | Buy |
50-day SMA: | 17.09 | Buy |
200-day SMA: | 10.53 | Buy |
8-day EMA: | 31.45 | Buy |
20-day EMA: | 26.71 | Buy |
50-day EMA: | 19.79 | Buy |
200-day EMA: | 12.53 | Buy |
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
IonQ Earnings Growth & IONQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.04 per share.
Neurogene Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IonQ Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |